- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 473/34 - Nitrogen atom attached in position 6, e.g. adenine
Patent holdings for IPC class C07D 473/34
Total number of patents in this class: 1071
10-year publication summary
|
90
|
115
|
91
|
102
|
86
|
75
|
64
|
45
|
50
|
14
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1879 |
26 |
| Novartis AG | 11238 |
24 |
| Ono Pharmaceutical Co., Ltd. | 454 |
24 |
| Sloan-Kettering Institute for Cancer Research | 413 |
18 |
| Intellikine LLC | 40 |
17 |
| AstraZeneca AB | 3042 |
16 |
| Epizyme, Inc. | 383 |
16 |
| Amgen Inc. | 3779 |
15 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
15 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
14 |
| Univerzita Palackeho V Olomouci | 135 |
14 |
| Rhizen Pharmaceuticals AG | 60 |
14 |
| Infinity Pharmaceuticals, Inc. | 122 |
13 |
| The Regents of the University of California | 18943 |
12 |
| Incyte Corporation | 918 |
12 |
| Memorial Sloan-Kettering Cancer Center | 1789 |
12 |
| F. Hoffmann-La Roche AG | 7958 |
11 |
| Gilead Calistoga LLC | 35 |
11 |
| Cancer Research Technology Limited | 542 |
10 |
| The Scripps Research Institute | 1364 |
10 |
| Other owners | 767 |